Virpax Pharmaceuticals, Inc.
VRPX · NASDAQ
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,513 | $17 | $1,871 | $1,866 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $38 | $273 | $128 | $506 |
| Total Curr. Assets | $1,556 | $304 | $2,591 | $3,130 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,556 | $304 | $2,591 | $3,130 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $75 | $13 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $2,259 | $2,500 | $2,500 |
| Total Curr. Liab. | $2,469 | $2,356 | $5,385 | $4,344 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $2,469 | $2,356 | $5,385 | $4,344 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$71,611 | -$68,221 | -$66,215 | -$62,765 |
| AOCI | $0 | $0 | $0 | -$0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$914 | -$2,052 | -$2,794 | -$1,213 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,556 | $304 | $2,591 | $3,130 |
| Net Debt | -$1,513 | -$17 | -$1,871 | -$1,866 |